NASDAQ:APHA

Aphria Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$15.38
0.00 (0.00 %)
(As of 05/7/2021)
Add
Compare
Today's Range
$15.38
$15.38
50-Day Range
$13.14
$18.37
52-Week Range
$2.78
$32.29
VolumeN/A
Average Volume21.83 million shs
Market Capitalization$4.87 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.67

Receive APHA News and Ratings via Email

Sign-up to receive the latest news and ratings for Aphria and its competitors with MarketBeat's FREE daily newsletter.


Aphria logo

About Aphria

Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.58 out of 5 stars

Medical Sector

472nd out of 2,100 stocks

Medicinals & Botanicals Industry

2nd out of 32 stocks

Analyst Opinion: 4.2Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Aphria (NASDAQ:APHA) Frequently Asked Questions

Is Aphria a buy right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Aphria stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in APHA, but not buy additional shares or sell existing shares.
View analyst ratings for Aphria
or view top-rated stocks.

What stocks does MarketBeat like better than Aphria?

Wall Street analysts have given Aphria a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aphria wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Aphria's next earnings date?

Aphria is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Aphria
.

How were Aphria's earnings last quarter?

Aphria Inc. (NASDAQ:APHA) issued its quarterly earnings results on Sunday, April, 11th. The company reported ($1.14) EPS for the quarter, missing the consensus estimate of ($0.04) by $1.10. The firm had revenue of $153.60 million for the quarter, compared to analysts' expectations of $172.01 million. Aphria had a negative trailing twelve-month return on equity of 2.30% and a negative net margin of 36.10%. The business's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period last year, the company earned $0.02 earnings per share.
View Aphria's earnings history
.

What price target have analysts set for APHA?

8 Wall Street analysts have issued 1 year price targets for Aphria's stock. Their forecasts range from $15.00 to $32.50. On average, they expect Aphria's stock price to reach $22.00 in the next year. This suggests a possible upside of 43.0% from the stock's current price.
View analysts' price targets for Aphria
or view top-rated stocks among Wall Street analysts.

Who are Aphria's key executives?

Aphria's management team includes the following people:
  • Mr. Irwin D. Simon, CEO & Chairman (Age 62, Pay $5.23M)
  • Mr. Carl A. Merton, Chief Financial Officer
  • Dr. Christelle Gedeon L.L.B., Ph.D., Chief Legal Officer & Corp. Sec.
  • Mr. James R. Meiers, Chief Operating Officer of Aphria Leamington
  • Ms. Denise Menikheim Faltischek, Chief Strategy Officer & MD of Aphria Germany (Age 48, Pay $449.68k)
  • Mr. John B. Sadler, VP of Investor Relations
  • Mr. Bernard Yeung, Sr. VP of Sales & Marketing
  • Mr. Victor Neufeld, Special Advisor (Age 67)
  • Mr. Cole Cacciavillani, Special Advisor (Age 66)
  • Mr. Randy Daigneau, Sr. VP of Supply Chain

Who are some of Aphria's key competitors?

What other stocks do shareholders of Aphria own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include AbbVie (ABBV), Alibaba Group (BABA), (CGC), Mastercard (MA), Square (SQ), Aurora Cannabis (ACB), Abbott Laboratories (ABT), Alteryx (AYX), Big Lots (BIG) and BlackRock (BLK).

What is Aphria's stock symbol?

Aphria trades on the NASDAQ under the ticker symbol "APHA."

Who are Aphria's major shareholders?

Aphria's stock is owned by many different institutional and retail investors. Top institutional shareholders include Morgan Stanley (1.32%), Alpine Associates Management Inc. (1.30%), Aristeia Capital LLC (0.82%), AdvisorShares Investments LLC (0.70%), Voloridge Investment Management LLC (0.63%) and Quinn Opportunity Partners LLC (0.48%).

Which major investors are selling Aphria stock?

APHA stock was sold by a variety of institutional investors in the last quarter, including Caption Management LLC, Voloridge Investment Management LLC, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Scotia Capital Inc., Vontobel Holding Ltd., Great West Life Assurance Co. Can, HighTower Advisors LLC, and Barclays PLC.

Which major investors are buying Aphria stock?

APHA stock was purchased by a variety of institutional investors in the last quarter, including Alpine Associates Management Inc., Morgan Stanley, Aristeia Capital LLC, Quinn Opportunity Partners LLC, AdvisorShares Investments LLC, Ergoteles LLC, Mirae Asset Global Investments Co. Ltd., and Vivaldi Asset Management LLC.

What is Aphria's stock price today?

One share of APHA stock can currently be purchased for approximately $15.38.

How much money does Aphria make?

Aphria has a market capitalization of $4.87 billion and generates $405.96 million in revenue each year. The company earns $-63,210,000.00 in net income (profit) each year or ($0.06) on an earnings per share basis.

How many employees does Aphria have?

Aphria employs 1,200 workers across the globe.

What is Aphria's official website?

The official website for Aphria is aphriainc.com.

Where are Aphria's headquarters?

Aphria is headquartered at 98 TALBOT STREET W., LEAMINGTON A6, N8H 1M8.

How can I contact Aphria?

Aphria's mailing address is 98 TALBOT STREET W., LEAMINGTON A6, N8H 1M8. The company can be reached via phone at (844) 427-4742 or via email at [email protected]


This page was last updated on 6/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.